BACKGROUND The American Association for the Study of Liver Disease recommends screening patients with cirrhosis for hepatocellular carcinoma(HCC)using imaging with or without alpha-fetoprotein every six ***,screening ...
详细信息
BACKGROUND The American Association for the Study of Liver Disease recommends screening patients with cirrhosis for hepatocellular carcinoma(HCC)using imaging with or without alpha-fetoprotein every six ***,screening rates remain *** To assess root causes of screening failure in a subspecialty hepatology *** The authors identified patients with cirrhosis seen in a subspecialty hepatology clinic and determined whether they underwent appropriate screening,defined as two cross-sectional images between five and seven months *** authors characterized the primary driver of screening ***,other hepatologists were surveyed to determine provider perceptions of screening failure *** 1034 patients were identified with an average age of 61 years and a mean MELD of 8.1±*** C virus was the most common cirrhosis etiology.489(47%)underwent appropriate *** demographic or clinical differences were detected between those who underwent appropriate screening and those who did *** most common etiologies of screening failure,in descending order,were:radiology unable to schedule timely imaging,provider did not order imaging,patient canceled follow up appointment,appointments scheduled too far apart,lost to follow up,no-show to radiology appointment,and provider canceled *** surveyed believed the most common cause of screening failure was no-show to *** Rates of screening were poor even in a subspecialty hepatology *** failure was mostly due to systemic factors such as radiology availability and time between hepatology appointments rather than individual error.
暂无评论